Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
accredited, adulthood, aeruginosa, algorithm, amikacin, appetite, Aradigm, Arikayce, Ashley, atypical, authoritative, autoimmune, aztreonam, bacteria, bacterial, bargaining, batch, Bayer, block, bronchi, bronchial, buildup, buy, cardiovascular, Cayston, CF, CFTR, ciprofloxacin, clarify, classification, climb, cocktail, colistimethate, colonization, colonized, compelling, configured, confirmatory, convened, COPD, corruptly, cough, crossed, crude, CuRx, cystic, destruction, developmental, device, diarrhea, digit, dilatation, dry, elasticity, encapsulation, eradicate, eradication, escrow, expectorate, exploring, fever, fluoroquinolone, fluoruquinolone, forfeited, GDP, GMP, Gould, handset, hearing, impending, Imputation, inaccurate, indefinite, infection, inflow, insignificant, Insmed, inter, intermediary, inthe, IPR, kansasii, labile, lag, legislature, levofloxacin, liposomal, load, loop, lung, macrolide, Marshfield, missing, Mpex, multiplied, mycobacteria, mycobacterium, nebulized, nebulizer, neuroprotective, nonclinical, noncurrent, NTM, oil, PARI, partnership, passage, phenotypic, Podhaler, prepay, proceeding, pronounced, provincial, PTAB, pulmonary, QUINSAIR, rationale, reclassification, recoup, repay, resection, residual, route, RP, RSU, salt, SARL, satisfactorily, Savara, simplification, smoking, sputum, standby, stickier, suicide, Surgical, thick, thicker, TOBI, tobramycin, tradename, transmembrane, Tripex, unchanged, uncollectible, unmarketable, unproven, unused, upfront, vancomycin, variance, verdict, viability, vialing, view, warehousing, workforce, Zirela
Removed:
abstinence, accumulated, acetaldehyde, acid, adiponectin, aggressive, alanine, alcohol, aldehyde, ALT, aminotransferase, artemisinin, Asia, Asian, aspartate, assumption, AST, auditing, averaging, avoid, biotech, Burr, CEO, commonly, communicated, constant, consumption, convivia, CRADA, CyNCh, cytokeratin, dehydrogenase, diet, digestive, discovered, drawn, East, estimating, examiner, expanding, fatty, Gastroenterology, hepatocellular, HepTide, histological, inhibitor, institute, instrument, juvenile, Korea, Laval, lesser, lifestyle, Lincoln, LPC, malaria, marked, Mayer, McGill, mediated, medicine, multicenter, NAFLD, NAS, NIDDK, nominal, obese, objective, originally, parasitic, Park, Parkinson, partnered, PDUFA, percent, percentile, Pilger, pill, poison, prioritization, processed, prototype, qualify, recapture, receptor, reducing, remedy, replacement, Rett, reviewing, scheduling, Seattle, Secretary, serum, spectrum, suggested, sustain, Switzerland, Taiwan, thought, ticker, travel, turnover, Uni, Universit, western, WntTide
Filing tables
Filing exhibits
Related press release
Horizon Pharmaceutical similar filings
Filing view
External links